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Abstract
Unvei led at the conclus ion of a  meeting of the Royal  Medical  and Chirurgical  Society  in 1861,[1] ‘Dr Nelson’s  Improved Inhaler’
was  one of the most important mi lestones  in the genes is  of rel iable treatment of respiratory a i lments  in the modern era.
Affordable and suitable for sel f-medication, the Dr Nelson’s  Inhaler offered s imple and rel iable rel ief for patients  with
respiratory and pulmonary a i lments . Conspicuous for i ts  modesty and s impl ici ty, i t was  one of the most widely produced,
reproduced, and used inhalation devices  in the final  third of the nineteenth century. By reconstructing the ‘biography’ of the
Nelson Inhaler, this  article wi l l  attempt to sketch a network of medical  and commercial  interests  and expertise in London which
al igned in the 1860s  to help establ ish inhalation as  a  popular, inexpensive, and trusted form of medical  therapy for pulmonary
ai lments . This  article wi l l  look at what connects  phys icians, apothecaries , and patients  in the era: the medicines  and
technologies  that were prescribed, made, bought, and which caused wel lness , s ide-effects , and even death. This  approach
al lows us  to develop a narrative of respiratory i l lness  as  i t was  experienced by practi tioners  and patients  a l ike.
Compone nt DOI: http://dx.doi .org/10.15180/170807/001
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Figure 1
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Nelson-type inhaler, London, England, late nineteenth century. Made by S. Maw, Son
and Thompson, 1870–1901
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Unvei led at the conclus ion of a  meeting of the Royal  Medical  and Chirurgical  Society (RMCS) – now the Royal  Society of
Medicine – in 1861 (Proceedings, 1861, p 399) ‘Dr Nelson’s  Improved Inhaler’ was  fi rst marketed with an announcement in The
Lancet in 1865 (1865a, p 152). Although mentioned only in pass ing in the records  of the RMCS, this  was  one of the most
important mi lestones  in the genes is  of rel iable treatment of respiratory a i lments  in the modern era. Affordable, suitable for
sel f-medication, requiring only steam and cheap non-prescription medication freely avai lable from druggists  and even
apothecaries  (British Pharmacopoeia, 1867, pp 363–364), the Dr Nelson Inhaler offered s imple and rel iable rel ief for patients
with respiratory conditions. Conspicuous for i ts  modesty and s impl ici ty, the Dr Nelson Inhaler was  one of the most widely
produced, reproduced, and used inhalation devices  of the period, a  fact which is  underl ined by the sheer number and di fferent
styles  of the inhaler present in the Wel lcome Medical  Col lection housed in the Science Museum. Indeed, i t i s  fa i r to describe the
Nelson Inhaler as  part of one of the ‘unloved col lections’ in Blythe House: i t i s  only one of a  vast selection of inhalation devices
that have not been regarded as  suitable for display because of their technical  focus  or lack of aesthetic appeal . Whi le steam
inhalers  were replaced in conventional  respiratory medicine by modern inhalation devices  (nebul izers , metered dose inhalers
and dry powder inhalers) from the mid-twentieth century onwards, Dr Nelson’s  Inhaler i s  s ti l l  produced today, but i t i s  now
more usual ly used by voice coaches.
By reconstructing the ‘biography’ of the Nelson Inhaler, this  article wi l l  attempt to sketch a network of medical  and commercial
interests  and expertise in London which al igned in the 1860s  to help establ ish inhalation as  a  popular, inexpensive and trusted
form of medical  therapy for respiratory and pulmonary a i lments . By looking at what connects  phys icians, apothecaries , and
patients  –  the medicines  and technologies  that were prescribed, made, bought, and which caused wel lness , s ide-effects , and
even death – we can develop a narrative of i l lness  as  i t was  experienced by practi tioners  and patients  a l ike. Pharmaceutical
therapies  – medicinal  products  procured from phys icians, apothecaries , or commercial  sources  such as  druggists  – were the
most common form of medical  care among the working and middle-classes  over the last three hundred years  or so and any
history of medicine us ing materia l  objects  needs  to begin with these cures . Lung disease was a  key issue in nineteenth-century
discourse and here the smal lest objects  and seemingly s imple technologies  (pi l l s , medicated steam, inhalation devices) enable
powerful  and provocative accounts  of both the private and socio-historical  dimensions  of medicine. Through i ts  widespread
avai labi l i ty the Dr Nelson Inhaler a l lows us  to develop multiple narratives  of medical  history and i ts  omnipresence speaks  to
the question of sel f-medication and health consumerism in the nineteenth century. Its  emergence from the orbit of the RMCS, on
the other hand, can also help us  to reconstruct a  surpris ingly thorough framework of what was, essentia l ly, qual i ty control ,
which was highly unusual  for pharmaceutical  technologies  in the nineteenth century. 
As  was  occas ional ly the practice at the regular meetings  of the RMCS, a  certain Dr Nelson presented his  prototype for a  new
therapeutic device which he had des igned and developed himself, at the close of bus iness  on 28 May 1861. Unl ike the in-depth
research papers  which were read out and discussed at the meetings  (and later publ ished in the Society’s  Proceedings and
Transactions, including papers  submitted by some of Europe’s  leading medical  luminaries  l ike Edward Jenner and Rudolf
Virchow), such presentations  of practical  devices  were recorded in short, perfunctory style and without much discuss ion. Dr
Nelson presented an inhaler, ‘i ts  cla ims to notice being, great ease and s impl ici ty of action; perfect cleanl iness; and an
arrangement of the mouthpiece by which is  secured economy in the use of any medicated ingredient that may be required for
inhalation’ (Proceedings, 1861, p 399). The inhaler cons isted of a  smal l  ceramic ‘pot’ with two protruding openings. The opening
at the top of the device could be blocked with a  cork into which a short metal  tube was inserted to form a mouthpiece (in later
vers ions  glass  was  sometimes used); another spout-l ike outlet to the front remained open. According to directions  in The Lancet,
hot water was  to be poured into the main body of the inhaler whi le the medication was to be soaked on a sponge inserted below
the corked opening at the top. The patient would inhale through the mouthpiece, drawing in a i r from the second opening through
the water and steam. This  would potentia l ly vaporise the medication on the sponge and del iver i t to the lung.[2]
Figure 2
The original  presentation of Dr Nelson's  Inhaler in The Lancet in 1865
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By 1865 Dr Nelson’s  device was being advertised widely in journals  such as  The Lancet (1865a, p 152), The Medical Times and
Gazette (1865b, p 160) and later in the British Medical Journal (1870, p 674). Now christened ‘Dr Nelson’s  Inhaler’, this  new
inhalation device was produced and marketed by S. Maw & Son from their London base in Aldersgate Street near the present-day
Barbican (Maw’s , 1866, p 82; Maw’s , 1870, p 66). Maw’s  was  a  wel l -establ ished surgical  instrument provider, but they also
sold less  specia l is t medical  products  for the domestic market such as  plasters , syringes  and bandages. Fol lowing in the
footsteps  of pioneers  l ike Mudge and Ramadge, the company had already begun advertis ing various  inhalers  in the early 1840s
and later sold devices  such as  ‘Startin’s  Pneumatic Inhaler’ for the new chloroform and ether anaesthes ia, making the company
an ideal  partner for inventors  of new respiratory devices  (Illustrated Catalogue, 2014, Vol . 2, p 125). 
Figure 3
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Dr John Mudge's  pewter inhaler, invented in 1778 and made by Wi l l iam Barnes,
Fleet Street, London
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Dr Nelson’s  Inhaler did not emerge into a  vacuum in the mid-nineteenth century. John Mudge had invented a pewter inhaler in
1778 and seems to have been the fi rst phys ician to use the word ‘inhaler’ in his  related case histories  (Mudge, 1778, p xi ).
Nelson’s  most immediate predecessor was  Francis  Ramadge, however. Ramadge developed an inhaler for treating tuberculos is
and asthma which he made more widely known through his  publ ication Consumption Curable in 1834 (Ramadge, 1834, pp 85–
87). Born in Dubl in and educated in Dubl in and Oxford, Ramadge was senior phys ician and lecturer at the Central  Infi rmary in
London, where he special ised in respiratory diseases. His  inhal ing pipe was a  narrow tube made of wood or ivory through
which the patient inhaled and exhaled. Ini tia l ly i t was  about four feet long, but later des igns  were much shorter and included a
whistle-type valve (Fi tch, Six Lectures, pp 93–95). The narrow tube provided res istance to inspiration and expiration, and the
therapy was des igned primari ly as  a  pal l iative ‘mechanical ’ exercise to strengthen the lungs  and expand the chest (Ramadge,
1834, p v). Interestingly, technologies  are sti l l  employed today for respiratory muscle training in chronic obstructive pulmonary
disease and cystic fibros is  us ing inspriatory/expiratory res istance devices  (Volska et a l , 2003; Battagl ia  et a l , 2009; van
Winden et a l , 1998). Whi le he acknowledged his  indebtedness  to experiments  with inhalation by René Laennec (Ramadge, 1850,
pp 9–12) and by Beddoes in Bristol  (Ramadge, 1835, pp 109–110), Ramadge was sceptical  about the efficacy of inhal ing medical
preparations: ‘As  to medicated vapours  […] upon the whole, I  have found them to be ei ther useless  or injurious’ (Ramadge, 1850,
p 10; see also Ramadge, 1834, p 91). Notwithstanding these misgivings  on inhal ing medicinals , the vers ion of the device
advertised by Maw & Sons  in the 1860s  shows Ramadge’s  pipe leading from a Mudge-type tin which would have been fi l led with
hot water infused with pharmaceutical  preparations  s imi lar to those used in conjunction with the Nelson’s  Inhaler (Maw, 1866,
p 81). This  would suggest that by the mid-nineteenth century both the mechanical  and pharmaceutical  uses  of inhalation had
become l inked, even i f Ramadge himself may have had l i ttle say in the des ign anymore (he died in 1867).
Figure 4
© www.inhalatorium.com, with kind permiss ion of Mark Sanders
An i l lustration of Francis  Ramadge's  inhal ing tube from his  publ ication,
Consumption Curable (1834)
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These technical  innovations  in inhalation therapy were not confined to Bri ta in. In continental  Europe cons iderable progress
was being made in developing nebul izers , a  more complex technology than the s imple steam inhaler favoured by Mudge,
Ramadge, and Nelson. In 1849 Auphon invented his  ‘atomizer’ in Euzet-le-Bains , the point of origin of a l l  further nebul is ing
devices  in the nineteenth century. His  invention involved shooting a  jet of medicated water at a  metal  plate, the resulting spray
being inhaled by the patient. The models  for this  device were the inhalation rooms at spa resorts , where water would be jetted
at the heated wal ls  of an inhal ing room, the pressure and heat producing a  spray which was inhaled by walking around the
room. In 1858 Jean Sales-Girons, wel l -known as  the editor of the respected journal  La revue médicale, introduced a portable
vers ion of this  nebul is ing effect, us ing a  smal l  pump operated by the patient himself to generate the pressure required to
produce the spray of medicated water which would be inhaled through a funnel-l ike mouthpiece (Sales-Girons, 1861, p 10). A
s imi lar device was developed and marketed by James Dewar in Scotland in the mid-1860s  (Dewar, 1868, p 48). Dewar
recommended a system of ‘dis infecting’ the nose, throat, and lungs  with sulphuric acid (p 9). In Germany, in 1862, the Berl in
lung special is t Louis  Waldenburg acquired one of Sales-Girons’ devices  and adapted i t with a  des ign fami l iar from perfume
sprays. He replaced the compl icated and i rregular pump in Sale-Girons’ device with Mayer’s  uterus  douche, which was to be
operated by hand (Anon, 1862, p 330). In the same year in Berl in J Bergson, Georg Lewin’s  successor in the Inhalatorium at
Berl in Univers i ty, advertised his  ‘Hydrokonion’ nebul izer on which he had been experimenting for some years  (Bergson, 1862, p
389). His  des ign replaced the hand-pump of previous  nebul izers  with two smal l  tubes  at right angles  to each other, us ing a
smal l  foot-pump and the Bernoul l i  pressure principle to draw water up through one pipe and generate a  spray with the other
(Bergson, 1863, pp 66–67). In Stuttgart Emi l  Siegle developed a widely respected steam spray inhaler which used heat to
generate the steam necessary for the Bernoul l i  principle, thereby rendering the hand-pump redundant (Siegle, 1864). His  device
consisted of a  glass  bulb fi l led with water from which one tube emerged to disperse the steam generated from by a smal l
paraffin lamp at the base of the device. The medication was carried through a short tube from a second glass  receptacle and
was nebul ised by the steam. The patient inhaled the medicinal  s team through a smal l  glass  funnel  (Siegle, 1864, p 25). Siegle’s
apparatus  was  manufactured and distributed in Bri ta in by Krohne and Sesemann from 1871 onwards  (Grossmann, 1994, pp
55–64; Anderson, 2005, pp 1139–1150; Sanders , 2007, pp 71–81) and al though under patent (‘Announcement’, 1864), i t was
quickly adapted by Bri tish phys icians  such as  James Maxwel l  Adams in Glasgow (Adams, 1878). Siegle’s  patent officer in
London, George Davies , clearly objected to the infringement and stopped Adams from marketing his  inhalation device. Siegle for
his  part seems to have copied Adams’ major innovations  to improve his  own device, adapting the boi ler and replacing the glass
components  with more sturdy metal  receptacles  and face-guards  (Adams, 1878, p 3). Owing to i ts  Europe-wide success , Siegle’s
inhaler i s  general ly held to be the fi rst nebul izer in the proper sense.
Figure 5
Advertisements  for some of the inhalation devices  made by S. Maw, Son & Thompson
in the British Medical Journal
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Whi le the Dr Nelson’s  Inhaler appears  somewhat old-fashioned by comparison with these nebul izers , i t was  in fact
revolutionary at the time for i ts  ease of use and patient-friendl iness . It predated the avai labi l i ty of the Sales-Girons-type and
Siegle-type nebul izers  in Bri ta in by some five years , and even after these other devices  were avai lable, the Nelson’s  Inhaler
required a fraction of the maintenance necessary for the smal l  technical  parts  in the nebul izers . Unl ike these other devices , Dr
Nelson’s  invention contained no complex tubing mechanisms to keep in working order and no sens itive components  l ike glass
which were prone to breaking and needed replacement. These factors  made Nelson’s  Inhaler s igni ficantly cheaper. It was
avai lable for a  relatively low price of between 4s  and 5s  6d. By contrast the Ramadge Inhaler cost 16s  (and required additional
purchases  of tubes, starting from 3s  each), Mudge’s  Inhaler started at 8s  (Maw Son & Thompson, 1866, pp 81–2), and when the
Siegle Inhaler emerged on the market in the 1870s  i t was  sold by Krohne & Sesemann for between 7s  6d and £3 5s  (Krohne,
1878, p 102).[3] The replacement parts  for these nebul izers  were pricey, costing between 1s  6d and 3s . In terms of cost and ease
of purchase, Dr Nelson’s  Inhaler was  s igni ficantly more customer-friendly. That said, given that average weekly earnings  of
labourers  and artisans  was  20s–30s  in 1860s  London, even the Dr Nelson’s  Inhaler would have been an exorbitant investment
for the working classes . This  suggests  that the main consumer group for the inhaler were the aristocracy and the growing
classes  of profess ionals , clerks , civi l  servants , and army officers , who earned in the region of £4–£5 a week, or £200–£300
annual ly (Porter, 1998, p 176).
The question of access ibi l i ty i s  no less  important than affordabi l i ty. Both Dewar’s  vers ion of the Sales-Girons  inhaler and
Siegle’s  inhaler were ini tia l ly only avai lable for purchase from the instrument makers  themselves  (in Kirkcaldy and London
respectively). From the outset the Dr Nelson’s  Inhaler could be purchased directly through pharmacies  or by order from Maw &
Sons for use at home. This  ease of access  a lso had therapeutic reasons: Sales-Girons, Bergson, and Siegle a l l  recommended
using their devices  under instruction in their cl inics  and inhalatoria, whereas  the Nelson’s  Inhaler could be used under the
instruction of a  phys ician (e.g. in private practices  or in hospitals ) or procured for private use at home. This  was  in part
because of safety aspects  involved: early vers ions  of the Siegle Inhaler were cri ticised for their dangerous  unrel iabi l i ty.
According to James Adams, the glass  boi ler was  fragi le and was prone to overflowing, potentia l ly scalding the patient: ‘the
water flowing over through the stream escape is  projected forcibly in the face of the patient’ (1878, p 10). In Adam’s  opinion ‘i t
required much persuas ion on the part of the phys ician, and cons iderable nerve on the part of the patient, to face Siegle’s  Patent
Inhaler after one or two experiences  of this  nature’ (ibid). Whi le steam inhalers  such as  Dr Nelson’s  device and nebul izers  such
as  those patented by Siegle and Adams both used the same bas ic method (i .e. s team) to transport medicinal  preparations, there
was l i ttle danger of accidental  scalding of this  nature with the s imple ceramic jug.
Figure 6
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Dr Siegle's  steam-powered inhaler, invented in Stuttgart in 1864, was  manufactured
in England by Krohne & Sesemann from 1871
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Alongs ide cost and maintenance, the Dr Nelson’s  Inhaler required very l i ttle assembly; in fact, i t could be used exactly as
purchased. The mouthpiece remained attached to the cork, which would be removed to pour in hot water, and other than
soaking the sponge with the medicinal  preparation the patient needed to do very l i ttle to gain rel ief. There were also vi rtual ly no
maintenance issues, other than occas ional ly replacing the sponge (any sponge would do) and washing out the ceramic pot. This
may have been one reason why the Dr Nelson’s  Inhaler was  popular among patients  and practi tioners . The medical  substances
for inhalation needed to be procured separately, and these included (according to the British Pharmacopoeia of 1867)
hydrocyanic acid, chlorine, tincture of iodine, creosote, and hemlock. Other common preparations  suggested in advertisements
but not l i s ted in the Pharmacopoeia included henbane, vinegar, and tincture of benzoin (e.g. Friar’s  Balsam), a l l  of which were
widely avai lable as  over-the-counter preparations  from apothecaries , druggists , and other unofficia l  retai ls  units .
Li terature, case histories , and personal  accounts  give l i ttle indication of how long each period of use would have lasted.
However, Horace Dobel l  recommends that the water should not exceed 170 degrees  when inhalation begins  (Dobel l , 1872, p
203), and Wi l l iam Abbotts  Smith general ly recommends three vapour inhalations  per day, with each sess ion lasting between 15
and 20 minutes  (1869, pp 60–61, p 72). Other inhalers  include detai led instructions  according to which patients  were ini tia l ly
recommended to undertake one dai ly sess ion of five minutes’ duration, ris ing to as  many as  ten dai ly sess ions  lasting up to
fi fteen minutes  as  the patient grew accustomed to the therapy (see Siegle, 1865, p 30). Repeti tions  of this  duration wi l l  not have
required much replenishment of hot water during each individual  s i tting with the Dr Nelson’s  Inhaler. 
Li ttle i s  known about Dr Nelson and there may have been many profess ional  reasons  for this  anonymity. One reason may have
been the l ink in the publ ic mind between inhalation therapy and quackery fol lowing a tria l  involving Dr Hunter (who cla imed to
have healed consumption through the inhalation of oxygen) and the Pall Mall Gazette in 1865–66 (Parry, 2000, pp 108–109).
This  could wel l  have made a respected phys ician reluctant to be identi fied with an inhaler he had invented regardless  of how
successful  or effective i t was  held to be by his  peers . There was clearly potentia l  for reputational  damage that could be incurred
by having one’s  name associated in advertisements  for inhalation devices  or remedies , with the whiff of so-cal led quackery
l i teral ly in the air. For example, in the fi rst edition of his  On Affections of the Throat and Lungs, Abbotts  Smith included a preface
distancing himself from Hunter’s  ‘ignorant’ and ‘reckless ’ treatments  (Abbotts  Smith, 1869, p 6). Al though quack medicine, as  an
outgrowth of the general  industria l i sation and commercial isation of medicine in the eighteenth and nineteenth centuries , was
by no means the sole terrain of unqual i fied tradesmen (qual i fied phys icians  and apothecaries  a lso engaged in commercial
activi ties  and the BMJ was  an important s i te for advertis ing), profess ional  phys icians  often based their superior status  on the
moral  integri ty of not advertis ing (Porter, 2000; Bartrip, 1995, pp 191–204). Given the profess ional  medico-scienti fic forum of
the RMCS in which Nelson’s  inhaler was  fi rst presented, we can assume that the inventor’s  anonymity was  in accordance with
an unwritten code of ethics  which held that the inventions  of scienti fic and medical  research should be made avai lable for the
benefi t of the widest publ ic poss ible (Gabriel , 2014). 
Whi le the patent records  for the nineteenth century in Bri ta in are far from complete, i t i s  tel l ing that there appears  to have been
no patent taken out on the Dr Nelson’s  Inhaler and indeed the speed with which other producers  advertised their own identical
vers ions  of the des ign (including, most notably, Boots  towards  the end of the nineteenth century) are evidence that there was no
patent granted. The phys ician’s  interest in the greatest medical  good over egocentric profi t may wel l  have been one reason for
his  pass ing over the des ign to Maw & Sons  to produce and market. Nevertheless , ci rcumstantia l  evidence al lows the poss ible
inventors  of Dr Nelson’s  Inhaler to be narrowed down to two candidates . Us ing the Medical Register, which was fi rst publ ished
in 1859 and included the names, addresses , and qual i fications  of a l l  l i censed medical  practi tioners  in the UK, 11 individuals
with the surname ‘Nelson’ who were qual i fied prior to 1860 can be identi fied, of which two – David Hume Nelson of Birmingham
(ca. 1812–1901, qual i fied 1848 in Edinburgh) and Thomas Andrew Nelson of London (ca. 1812–1894, qual i fied 1834 in
Edinburgh) – are the most probable candidates .
David Hume Nelson led a colourful  and notable l i fe. Born in Edinburgh, he moved to London around 1835, spent some time in
prison for theft, returned to Edinburgh to qual i fy for his  MD in 1848, before being elected phys ician at the Queen’s  Hospital  in
1849 and joining the Faculty at The Queen’s  Col lege in Birmingham shortly afterwards  (Sanders  and Harper, 2014). David Hume
Nelson’s  qual i fications  in respiratory medicine are a lso wel l  founded, having publ ished his  dissertation On the principles of
health and disease in 1850 and featured in a  series  of case histories  in the Provincial Medical and Surgical Journal (PMSJ, a
forerunner to the BMJ) around 1850–1851 (Anon, 1850a; Anon, 1850b; Anon, 1851). As  part of a  ‘s trictly introductory’ (Anon,
1850c, p 41) series  of cl inical  lectures  seria l i sed in the PMSJ between 1851 and 1853 (a lso publ ished in book form in 1850),
David Nelson also gave three lectures  on ‘The morbid condition of the lungs  and respiratory tubes’ (Nelson, 1851, 1853a and
1853b). It i s  notable that inhalation is  not mentioned as  a  form of treatment in any of these lectures , focus ing instead on more
traditional  ‘heroic’ humoral  cures  such as  blood-letting, cupping, leeches  and the use of mercury, antimony, and oral
expectorants . Fol lowing these early publ ications, David Hume Nelson seems to have turned his  attention to other cl inical
matters , publ ishing a  series  of articles  in the British Medical Journal between 1860 and 1863 on ‘ferro-albuminous’ treatments
and peptic acids , a l l  of which resulted from a ten-year cl inical  s tudy in Birmingham into Bright’s  disease concluding in 1860
(Nelson, 1860a; Nelson 1860b). 
Whi le David Hume Nelson was a  renowned phys ician and indeed publ ished results  from his  research – a lbeit on a completely
unrelated topic to inhalation – in the issue of the BMJ immediately fol lowing the record of the RMCS meeting that mentions  the
presentation of the inhaler (Nelson, 1861, p 645), Thomas Andrew Nelson is  vi rtual ly unknown. It i s  known that Thomas Andrew
qual i fied in Edinburgh with a  dissertation on ‘Phthis is  pulmonaris ’ in 1834 (and thus  had special ised in a  related topic; see
Edinburgh Journal, 1834, p 490). He then relocated to London where he l ived and worked in the area around Regent’s  Park, at
fi rst in Wimpole Street, then in Nottingham Terrace off York Gate.[4] Although he publ ished few or poss ibly no writings
whatsoever, Thomas Andrew Nelson was the only Nelson who held a  Fel lowship at the RMCS in the period in question, and his
res idence in an exclus ive part of Marylebone is  evidence that a l though we know l i ttle about him, his  practice clearly thrived
over a  cons iderable period of time in the geographical  area favoured by the Harley Street establ ishment.[5] Indeed, i t i s  notable
that highly respected phys icians  and experts  in respiratory diseases  and their treatment l ike Si r Charles  Scudamore also l ived
in Wimpole Street and around York Gate in the period immediately fol lowing Thomas Nelson’s  relocation to London around
1835, suggesting a  community of l ike-minded inhalation special is ts  within the RMCS and in close geographical  proximity (the
l ist of members  includes  addresses  for Nelson, Scudamore, and other establ ishment phys icians). The Proceedings make i t
difficult to establ ish the identi ty of the inventor with complete certainty: a  Dr Nelson only appears  twice in the minutes  of the
meetings  in this  period. Unl ike external  speakers  or guests  who are l i s ted with their ful l  names, ti tles , and affi l iations, however,
Dr Nelson is  recorded without his  fi rst name, upholding the usual  practice when referring to members  of the Society. As  Thomas
Andrew was the only Nelson in the RMCS at this  time, this  could at least indicate his  intel lectual  ownership. Thomas Andrew
seems to have reti red in 1890 or 1891 because his  name disappears  from the l i s t of members  several  years  before his  death is
recorded in the Marylebone parish records  for the year 1894.[6]
Although the inventor’s  identi ty remains  somewhat uncertain, Dr Nelson’s  decis ion to work with Maw & Sons  is  eas ier to
reconstruct and understand. Not only was  the company at the forefront of manufacturing and supplying medical  equipment to
hospitals  and medical  practi tioners  in Victorian Bri ta in, they had themselves  a lready marketed older ceramic inhalation
devices  and displayed these at the 1862 Exhibition. In 1835 Solomon Maw had taken over the company, original ly founded by
his  father George Maw in 1814, from his  elder brother John Hornby, and fol lowing Solomon’s  death in 1861 his  son Charles  ran
the bus iness  in partnership with John Thompson (Anon, 1917, p 42). Maw & Sons  were particularly wel l  suited to making
ceramic instruments  as  one of George’s  sons, John Hornby Maw, had settled in Shropshire by 1850 and had set up a new
business  des igning and manufacturing encaustic ti les , fi rst in Worcester, then in Brosely, and final ly Benthal l  (Herbert, 2005).
With these fami ly connections  to the ceramics  industry in Shropshire, and their own manufacturing and marketing expertise, S.
Maw & Son were an obvious  partner for the inventor. 
The Dr Nelson Inhaler emerged into a  medical  market with a  clear demand for rel iable therapies  for the various  respiratory
diseases  bl ighting the towns and ci ties  of industria l  Europe. Rapid urban development had led not only to the spread of
waterborne diseases  l ike typhoid and cholera, but a lso to a  peak in a i lments  l ike asthma and consumption, with fogs , smoke,
and other pol lutants  a  cause of a lmost constant suffering throughout the 1800s. In the Medical Times and Gazette the London
Fog that ki l led 273 people as  a  result of bronchial  complaints  in 1873 was reported as  ‘one of the most disastrous  this
generation has  known. To persons  with cardiac and respiratory disease i t has  in numerous instances  proved fatal ’ (Anon, 1873,
p 697). Indeed i t i s  tel l ing that Maw’s  – one of the largest suppl iers  of medical  and surgical  instruments  in Bri ta in – displayed
various  patented inhalers  at the International  Exhibition of 1862 (Illustrated Catalogue, 2014, p 125), a  reflection of the close
and di fficult relationship between Victorian industria l i sation and medical  innovation.
Inhalation was becoming recognised as  a  quicker, less  dangerous, less  invas ive, and pharmacological ly more effective manner
of medication for consti tutional ly weak consumptive patients . As  indicated by the origins  of inhalation therapies  across  Europe
in spa resorts , the main forms of pal l iative therapy involved travel l ing to suitable locations  such seas ide baths  and thermal
baths, or even further afield to warmer cl imates  (Waldenburg, 1864, p 2; Hassal l , 1879), but this  was  unaffordable for a l l  but
the very affluent classes . More inexpensive forms of therapy included smoking stramonium and other substances, but a l though
these provided rel ief, they were also known to have narcotic s ide-effects . Likewise, given that asthma was frequently held to be a
nervous and/or spasmodic disorder, the ubiquitous  opium was recommended as  a  relaxant in the form of pi l l s  or tinctures
such as  laudanum (Waldenburg, 1864, p 3; Thomson, 1866, p 37), but this  was  known to have s igni ficant s ide-effects  such as
constipation and addiction. Surgery was  seldom considered suitable, and was concentrated on the upper respiratory tract with
operations  on the larynx or tons i ls . Inhalation, by contrast, was  growing more and more popular among phys icians. In 1829,
James Murray had already argued that ‘bathing the lungs’ ensured a more focused del ivery, ‘local  affections  […] which can be
directed to and confined upon any point or part affected’ i s  the preferred form of pharmaceutical  therapy (Murray, 1829, p 168).
Murray mentions  Mudge’s  pewter inhaler as  the impetus  for the renaissance of the medical  procedure of inhal ing vapours  in
the mid-1800s, but he is  a lso cri tical  of the practice and technology of inhalation: ‘It i s  needless  to say that they [the inhaled
vapours] do l i ttle good in the manner they are appl ied’ (ibid). Five years  later, Charles  Scudamore praises  inhalation for not
affecting the stomach of respiratory patients  in addition to their pulmonary distress  (Scudamore, 1834, pp 136–7). When Dr
Nelson emerged with his  new double-valve inhaler in the early 1860s  i t was  no surprise that one of the fi rst advertisements  for
the device recommended the inhaler’s  s impl ici ty (Anon, 1865b, p 160).
By the mid-1860s  medical  journals  and other publ ications  were ful l  of advertisements  and announcements  of new types  of
inhalers , hence i t i s  not surpris ing to find Dr Nelson’s  Inhaler being advertised widely in journals  such as  The Lancet and the
British Medical Journal in 1865. But profess ional  col leagues  l ike Abbotts  Smith in his  On Affections of the Throat and Lungs and
their Treatment by the Inhalation of Gases and Medicated Vapours (1869, p 72) a lso recommended the device to their patients .
Abbotts  Smith a lso provides  the theoretical  background for the new-found populari ty of inhalation therapy in the mid-
nineteenth century. Whi le stress ing the impact of urbanisation and industria l i sation with their economic and environmental
factors , he points  towards  a  paradigm change in drug del ivery which seems to have started towards  the end of the eighteenth
century (Abbotts  Smith, 1869, pp 16–19). Whi le inhalations  had been recommended in Egyptian, Indian, Greek and medieval
treatises , most notably by Hippocrates  and Maimonides,[7] Phi l ip Stern’s  marketing of his  own recipe of balsamic vapours  in
Medical Advice to the Consumptive and Asthmatic Peoples of England of 1764 marks  the beginning of a  process  that led to
Mudge’s  pewter inhaler. Stern was one of the fi rst commercial  scale producers  of inhalers  and inhalants  and his  ‘pamphlet’,
which was a imed at the broader publ ic, went through multiple editions; the price he seems to have paid for this  popular focus
was that he was shunned by the medical  profess ion of the day and his  work is  largely unreferenced anywhere. Experimentation
with oxygen and nitrous  gases  by Thomas Beddoes and Humphry Davy at the Pneumatic Insti tute in Bristol  in the 1780s  and
1790s confi rmed the suitabi l i ty of the lungs  as  a  s i te for the absorption of medicinal  products . Fol lowing Beddoes’ lead,
widespread experiments  with oxygen and gas  therapy in continental  Europe, and France in particular (Lavois ier, Demarquay),
showed a more widespread interest in the inhalation method around 1800. After tra ining to administer foul -tasting medicines
and invas ive therapies  l ike any other eighteenth-century phys ician, Beddoes noted ‘the eagerness  with which these patients
looked forward for their dose of a i r’ – the stimulus  for a  less  invas ive form of therapy was clearly motivated by these
experiments  (Beddoes, 1799, p 20; see also Jay, 2009; and Vickers , 2004). The publ ici ty surrounding the Pneumatic Insti tute’s
experiments  with nitrous  oxide around 1798–1800 was also the impetus  to wider experimentation with chloroform and
laughing gas  as  anaesthetics  on both s ides  of Atlantic in the 1830s  and 1840s, with the successful  experiments  by James Young
Simpson in Edinburgh confirming the abi l i ty to generate pharmacological  effects  through pulmonary drug del ivery.
This  changing understanding of drug del ivery was  obvious ly of particular importance for phys icians  interested in respiratory
i l lness . Scudamore introduced the findings  of his  cl inical  tria ls  of inhalation in respiratory patients  as  fol lows: ‘It consti tutes  a
new method of treatment to administer by inhalation those medicinal  agents  which the science of modern pharmaceutical
chemistry has  brought to l ight; and i t i s  my object […] to show that they are capable of exerting a  very important and beneficia l
influence in certain states  of pulmonary and bronchial  disease’ (Scudamore, 1830, p 2). Apart from programmatical ly
highl ighting the innovative nature of this  therapy, Scudamore also points  towards  a  changing understanding of pharmaceutical
therapy to a  more local ised and directed form of drug del ivery when he writes  that the ‘rational i ty of applying some remedial
agent in a  direct manner to the seat of the disease wi l l  not be questioned’ (ibid). Simi larly, Murray demands appl ication of
medicinals  ‘local ly to the lungs’, cla iming ‘i f you inhale vapour, which condenses  in the cel ls , at least a  smal l  part of i t, i t
bedews and covers  the surfaces  and ulcerations’ of the lungs, hence acting directly at the source of the i rri tation (Murray, 1829,
p 173 and p 180). Alongs ide i ts  appeal  as  a  less  phys ical ly invas ive remedy, the practice of inhalation may therefore a lso be
seen as  part of a  general  trend towards  targeted drug del ivery and action emerging in mid-century Victorian Bri ta in.
As  these empirical  tria ls  show, the inhalation device was used by hospitals  for the poor, but i ts  immediate target audience wi l l
have most l ikely been wealthy customers  who could afford to purchase the inhaler and who could thus  be encouraged to sel f-
medicate. However, the economic means to buy proprietary medicines  were not l imited to very wealthy patients  – the type of
private patients  Scudamore and Thomas Nelson wi l l  have seen around Marylebone – and the ease of access  to the Nelson
Inhaler and related medicines  l ike Friar’s  Balsam suggest that less  prosperous  patients  were also able to gain some rel ief from
respiratory conditions. Such groups wi l l  have been more immediately affected by the environmental  pol lution of the industria l
age than wealthy patients  around Regent’s  Park, of course, and in acute cases  those patients  who were too poor to be able to
sel f-medicate wi l l  a lso have had access  to treatment by phys icians  l ike Wi l l iam Abbotts  Smith who worked in Finsbury
Dispensary and the Metropol i tan Free Hospital , both in the immediate vicini ty of Maw’s  base to the East of the City of London.
Abbotts  Smith refers  to studies  of patients  with depositions  of coal -dust in their lungs  in the Sheffield area (1869, p 81) and to
‘chimney-sweeps, bakers , and dock-labourers ’ (1869, pp 81–82). Indeed, he clearly drew on such patients  as  the cl inical
evidence base for his  publ ished writings , which contain various  formulations  which suggest that his  therapeutic models  are
based on evidence he has  gathered in the cl inical  environment. See, for example: ‘Several  of my patients  […]’ and ‘cases  have
come under my notice’ (Abbotts  Smith, 1866, p 32); ‘The inhalation of oxygen has  been found very useful  in preparing del icate
patients  for surgical  operations, by restoring their vi ta l  powers  […]’ (Abbotts  Smith, 1869, p 27); ‘At this  stage, the effects  vary
according to the individual ’ (ibid, p 48). In these publ ications, he also recommends the Nelson Inhaler unconditional ly for
hospitals  and private patients  a l ike:
There are numerous methods by which the patient may be enabled to inhale the steam, as , for instance, from a jug or bas in
containing hot water, or by breathing through a sponge which has  been previous ly dipped in boi l ing water, and then
partia l ly wrung out. Several  forms of apparatus  have also been devised for this  purpose; two of the most efficient of these,
whether for the inhalation of s imple steam or of medicated vapour, are Nelson’s  Inhaler and Sturt’s  Inhaler. (ibid, p 72)
The fact that a  phys ician recommends the Nelson Inhaler here on the bas is  of empirical  evidence from a cl inical  environment is
quite a  surpris ing finding in the broader context of nineteenth-century healthcare.
Beginning with the ini tia l  presentation to the RMCS in 1861, and subsequently sanctioned in the Society’s  officia l  publ ication,
the Proceedings, the speed with which the Dr Nelson’s  Inhaler was  recommended in the various  media of the day is  somewhat
surpris ing. It i s  di fficult to compare an inhaler to products  such as  pi l l s , tinctures , and tonics , but these may provide a useful
point of comparison. Concurrent developments  in communication media, the expansion of the press  landscape, and the speed
of the postal  network al l  ass isted in the rise to fame and widespread use of preparations  such as  the laudanum brand ‘Black
Drop’, tonics  l ike ‘Lydia Pinkham’s  Vegetable Compound’, and later Burrough’s  and Wel lcome’s  ‘Tabloid’ brand of pi l l s , with
their ful ly-fledged advertis ing campaigns. In mid-Victorian Bri ta in, advertis ing was sti l l  cons idered the domain of ‘quack’
medicines, however. In an age in which some doctors  were nevertheless  far from media shy (Morel l  Mackenzie, as  an ENT
special is t and inventor of the so-cal led ‘Eclectic Inhaler’, notorious ly courted media attention, not least during his  treatment of
the Pruss ian crown prince’s  throat cancer in the 1880s), the inventor of the Nelson’s  Inhaler seems to have had l i ttle pretention
to publ ic renown either for his  device or for himself. A comparison to the other inhalation devices  mentioned in this  article
shows just how unusual  Dr Nelson’s  reticence was in this  regard; Waldenburg (1862), Siegle (1864), Dewar (1868), Adams
(1878), and indeed other phys icians  l ike Mackenzie, with his  ‘Eclectic Inhaler’ (1880) a l l  advertised their inventions  with
extens ive user manuals  and booklets , even i f these were aimed either at profess ional  col leagues  or were distributed with the
devices  after they had been purchased. Dr Nelson’s  reticence to use his  profess ional  respectabi l i ty more vis ibly could have
been a hindrance to the inhaler’s  reception, despite his  good connections  in the medical  community in ei ther London or
Birmingham. How should we understand the success  of the device, then?
The unusual ly speedy success  seems to have been the result of widespread acceptance among col leagues, the commercial
interests  of Maw & Sons, and final ly the relative value for money already discussed above. For serious  phys icians  or
pharmacists , the s ign of acceptance for a  pharmaceutical  preparation was i ts  professional acceptance in the British
Pharmacopoeia, the officia l  sanctioned l i s t of medication, rather than i ts  populari ty or profi tabi l i ty. For pharmaceutical
technology the equivalent acceptance came in the form of recommendations  in therapeutic handbooks, scienti fic studies , and
its  use in profess ional  practice. This  can be measured by the articles  written by col leagues  in specia l is t journals  read primari ly
by other profess ionals  and in more popular domestic handbooks  in the final  third of the nineteenth century. Readers  of Spencer
Thomson’s  revised Dictionary of Domestic Medicine and Household surgery in 1866, for example, wi l l  have found detai led notes  –
including two large i l lustrations  – on the Dr Nelson’s  Inhaler (‘an apparatus  for the inhalation of ether, chloroform, henbane,
creosote, vinegar etc., in affections  of the throat and bronchial  tubes, asthma, consumption, etc.’) in the relevant article on
inhalers  (Thomson, 1866, p 52). In a  lecture publ ished in the BMJ and subsequently republ ished in various  regional  medical
journals  across  Bri ta in and North America, the eminent Professor of Materia  Medica and Medicine at King’s  Col lege London,
George Johnson, a lso spoke of having used the inhaler in advanced respiratory patients  (Johnson, 1869, p 434). Final ly, R
Douglas  Powel l  of the Brompton Hospital  for Consumption and Diseases  of the Chest, wri ting in The Lancet in 1877 recommends
that inhalations  ‘may be taken very wel l  from a deep jug or a  Nelson’s  inhaler with the sponge removed’ (Powel l , 1877, p 152).
Col leagues  were recommending Dr Nelson’s  Inhaler on the bas is  of their experience in a  cl inical  environment, a  s ign of esteem
that may go some way to explaining the great success  of the device in the period.
Such profess ional  acceptance took time, however, and certainly more than the short period between 1861 (when Dr Nelson’s
invention was announced) and 1865 (when i t was  fi rst marketed) would have al lowed. Here we must cons ider the role of Maw &
Sons, the original  producers  and marketers  of the device. There was indeed a relatively robust advertis ing and marketing
campaign surrounding the Dr Nelson’s  Inhaler in the 1860s  and 70s  across  various  media (from newspapers  to profess ional
journals), and this  could have potentia l ly brought the device close to accusations  of commercial  interests , and hence quackery.
Since Dr Nelson had clearly forfei ted his  ownership of the device, however, these commercial  interests  were legitimate and
didn’t impact on the medical  integri ty of i ts  inventor. From the outset, the advertis ing a lso made a point of avoiding the
impress ion of a iming at a  mass  audience. The fi rst announcement in The Lancet was  targeted directly at ‘medical  men’ (1865a, p
152) and subsequent advertis ing campaigns  focused on journals  such as  the BMJ; advertisements  in more popular newspapers
towards  the end of the century avoided any form of excess ive rhetoric. Dr Nelson’s  Inhaler brought together profess ional  dignity
and acceptance, then, but a lso commercial  know-how at an arm’s  length from the medical  profess ional  himself, and final ly a
competitive pricing structure, making the device affordable both for publ ic cl inics  or hospitals  and private patients  a l ike. The
combination of commercial  and profess ional  acceptance is  perhaps  the most notable feature of the Dr Nelson’s  Inhaler.
Unusual  in that i t profi ted immensely from both profess ional  and commercial  networks  of acceptance, marketing, distribution
and use, the Dr Nelson’s  Inhaler enjoyed a remarkably speedy rise to fame in the medical  marketplace of the 1860s  and 1870s.
Requiring only steam and cheap non-prescription medication, and readi ly avai lable from multiple retai l  outlets  – in hospitals
and from personal  phys icians, by mai l  order catalogue, and from high street chemists  or later even drug stores  l ike Boots  – the
device was one of the most widely used inhalers  in the nineteenth century. With i ts  potentia l  to take the treatment of respiratory
i l lness  out of hospital  wards, phys icians’ cl inics  and spa resorts , the Dr Nelson’s  Inhaler offered a rel iable form of sel f-
medication against environmental ly induced conditions  such as  bronchitis , catarrh, asthma, and more serious  conditions  such
as  the croup or consumption. Simi larly, sel f-medication with the inhaler was  connected with prophylactic treatment of
respiratory conditions. Rather than al lowing one’s  health to deteriorate, hence requiring costly treatment by phys icians  or in
hospitals , many of the domestic handbooks  and medical  treatises  point towards  personal , preventative treatment in the
comfort of the home. Spencer Thomson writes , for example: ‘It i s  probable that the s low, imperceptible, but continual  breathing
of an atmosphere impregnated with such medicinal  agents  […] is  more l ikely to be of service than their temporary use in more
powerful  doses’ (1866, p 305). Abbotts  Smith views inhalation as  a  form of breathing training, helping to manage the lung
function (1866, p 70–71). The emphasis  on individual  management of respiratory conditions  made poss ible by the Dr Nelson’s
Inhaler would later establ ish i tsel f as  a  key component in the treatment of asthma patients  from the mid-1950s  onwards, as
new pressurised metered dose inhalers  (pMDIs) made sel f-treatment more rel iable and effective (Anderson, 2005, p 1143–
1144). Indeed, the instigator behind Riker and Du Pont’s  fi rst pMDI in 1956, George Maison, explained that the origins  of the
project lay in his  wish to s impl i fy the treatment of his  own asthmatic daughter, finding existing hand-held nebul izer devices
unsuitable to outpatient use (see Grossmann, 1994, p 59). Whi le the form of medication may have changed from medicated
steam to bronchodi latory powders  and steroids  (Sanders , 2007, p 79), the ‘cleanl iness , portabi l i ty, and cheapness ’ of the Dr
Nelson’s  Inhaler mentioned in The Lancet (1865a, p 152) are qual i ties  which are sti l l  central  to inhalation devices  today.
Indeed, a  recent regulatory-industria l  col laborative workshop was devoted precisely to developing a  patient-use focus  in
inhalation device des ign (Roche et a l , 2017). Since the mid-twentieth century with Riker’s  pMDI and now especial ly in the
twenty-fi rst century, medical  device development is  returning to Dr Nelson’s  maxim of ease and s impl ici ty of use.
Of course, sel f-medication was by no means unproblematic in the nineteenth century and need not necessari ly be cons idered an
indicator of medical  or pharmaceutical  modernisation. Ineffective and even dangerous  household remedies  and patent
medicines  were frequently advertised and consumed in s imi lar ways  to the Dr Nelson’s  Inhaler, much to the distress  and anger
of the profess ional  medical  classes . A comparison with various  other ‘household’ remedies  for asthma and consumption in the
second hal f of the nineteenth century confi rms this . Alongs ide more rel iable remedies  and devices  l ike ‘Vapo-Cresolene’ lamps,
pi l low inhalers , oxygen bars , asthma cigarettes  and pipes  (in ascending order of danger), we also find less  serious  remedies
such as  ‘Si r Hiram Maxim’s  Pipe of Peace’ (Sanders , 2007, p 77), the ‘Carbol ic Smoke Bal l ’, which gained notoriety because of i ts
role in a  legal  case which defined the l imits  of promises  made in advertisements  (Snel l , 2001), and even Robert Moffatt’s
‘Ammoniaphone’ (see Dickson, 2017). Given that the Dr Nelson’s  Inhaler was  accepted in both commercial  and profess ional
terms, this  was  a  form of sel f-medication for in- and outpatients  that was  medical ly legitimised. Moreover, i t was  sanctioned in
more formal  terms as  a  treatment method in academic publ ications  such as  case histories , medical  textbooks, and more widely
in domestic handbooks, whi le the incorporation of steam inhalations  in the British Pharmacopoeia in 1867 placed the Dr
Nelson’s  Inhaler at a  remove from these i rregular forms of treatment. 
Inhalation therapies  in the second hal f of the nineteenth century typical ly involved either volati le or combustible materia ls  for
smoking or vaporisation (Sanders , 2007, p 79), including medicines  of herbal  origin such as  stramonium, a  direct l ink to
modern antimuscarinic therapies . However, non-volati le, puri fied smal l  molecular weight drugs  began to emerge from the early
twentieth century including adrenal ine (extracted from adrenal  glands; see Burnett, 1903) in 1903, atropine (puri fied from
Hyoscyamus extracts ; see Terray, 1909), ephedrine (structural ly-related to adrenal ine, puri fied from Ma Huang herb; see Chen
and Schmid, 1924), and cortisone treatment by the 1950s  (see Carryer, 1959). This  required an evolution of device technologies
to disperse bulk l iquids  into aerosol  droplets  that contained the dissolved (or suspended) drug, or to disperse ultra-fine bulk
powders  of the drug into inhalable aerosols  under mechanical  or aerodynamic forces. The result of this  was  the invention and
development of the forerunners  of modern inhalation devices  including jet nebul izers  (e.g. the Pneumostat, widely used from the
1930s but sti l l  general ly housed in surgeries  and pharmacies) or hand bulb nebul izers  such as  the Parke-Davis  Glaseptic, and
Abbots ’ Aerohaler (1948), which is  clearly comparable to modern dry powder inhalers , and ultimately the pMDI in the 1950s
(Sanders , 2007, p 79).
Whi le steam inhalers  were replaced in conventional  respiratory medicine by modern inhaler devices , Dr Nelson’s  Inhaler i s
notable for how i t helped to establ ish inhalation as  a  popular, inexpensive and trusted form of medical  therapy for respiratory
ai lments  in the 1860s. In many ways, i ts  inconspicuous ceramic form may wel l  be one reason why i t has  survived in such
numbers  to be able to tel l  this  story: unl ike later low-cost devices  from France and Bri ta in which were made of enamel , the
robustness  of the Dr Nelson’s  Inhaler has  helped i t to survive in museum col lections  and antique shops to the present day. As
such, the Dr Nelson’s  Inhaler can be seen as  an important mi lestone in the development of modern outpatient treatment of
asthma and other respiratory conditions. This  was  not least the case because of i ts  affordabi l i ty and flexibi l i ty, offering s imple
and rel iable rel ief for respiratory and bronchial  patients  both in a  cl inical  and a domestic environment. Its  emergence from the
orbit of the RMCS can also help us  to reconstruct a  surpris ingly thorough framework of what was  essentia l ly qual i ty control
and profess ional  recommendation, which was highly unusual  for pharmaceutical  technologies  in the nineteenth century. The
commercial  interests  of S. Maw & Son ensured that the inhalation device was widely and successful ly marketed and distributed
without encroaching on the practices  and disrepute of the patent medicine sector of the nineteenth-century medical  market. As
such the seemingly inconspicuous Dr Nelson’s  Inhaler enables  us  to tel l  a  far-reaching story of pulmonary and respiratory
disease and their treatment in the nineteenth century.
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1. This  forerunner to the Royal  Society of Medicine was founded in 1805 and brought together prominent London
phys icians  and surgeons (chirurgical  = surgical ); i t was  granted a royal  charter in 1834.
2. In a  recent experimental  s tudy, the authors  of this  article could establ ish the rel iabi l i ty of the Nelson Inhaler us ing
modern testing methods; see Murnane et a l , 2017.
3. A competitor, Arnold, sold i t at a  cost of between 7s  6d and £2 7s  6d (Arnold, 1876, p 218).
4. See the yearly l i s ts  of Fel lows in the Society’s  journal , Medico-Chirurgical Transactions, from 1835–1888.
5. In the period between 1850 and 1890 the Society’s  records  l i s t Thomas Andrew Nelson as  the only phys ician with this
surname among the Fel lowship.
6. Register of Deaths  for the District of Marylebone, Vol . 1a, p 468; see http://www.freebmd.org.uk
7. The former describes  a  pot with a  perforated l id with a  straw inserted for the inhalation of vapours , making i t an ancient
predecessor of the Nelson Inhaler; see Jackson, 2009, pp 31–37.
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